Your Article Summary
Limiting the Morbidity of Inguinal Lymphadenectomy for Metastatic Melanoma
Cancer Control, 06/30/09
Sarnaik AA et al. - The morbidity of inguinal lymphadenectomy can be substantial, several straightforwardpre- and postoperative measures can be instituted to limit morbidity. Controversy persists regarding the indicationsfor and benefit of pelvic lymphadenectomy, saphenous vein preservation, and sartorius muscle transposition. A multi-institutional trial is currently in progress to investigate the safety of avoiding lymphadenectomy in patients with microscopic metastases in the sentinel node.
Related Articles
Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy
The Oncologist, 10/30/09
Relevance Score: 70%
Loss of SNF5 expression correlates with poor patient survival in melanoma
Clinical Cancer Research, 10/12/09
Relevance Score: 70%
Results of a multicenter, randomized, double-blind phase 2/3 study of lenalidomide in the treatment of pretreated relapsed or refractory metastatic malignant melanoma
Cancer, 10/30/09
Relevance Score: 69%
Dormancy of metastatic melanoma
Pigment Cell & Melanoma Research, 11/11/09
Relevance Score: 68%
Metastatic cutaneous malignant melanoma: Spectrum of imaging findings and the role of multimodality imaging
Journal of Medical Imaging and Radiation Oncology (JMIRO), 10/05/09
Relevance Score: 68%
Today in Dermatologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Tumour seeding in a case of malignant melanoma due to fine needle aspiration of a lymph node
Journal of Plastic, Reconstructive & Aesthetic Surgery, 12/01/09
Self-reported screening for skin cancer in Austria
European Journal of Dermatology, 12/01/09
De novo intraepidermal epithelioid melanocytic dysplasia: an emerging entity
Journal of Cutaneous Pathology, 11/30/09

See Latest Articles